Mounjaro 12.5mg KwikPen
Manufacturer:
Eli Lilly and Company India Pvt Ltd
Salt Composition: Tirzepatide (12.5mg)
Action Class: Dual GIP and GLP-1 Receptor Agonists
Packaging: 3.0 ml in 1 pre-filled pen
Uses
To improve glycemic control in adults with Type 2 diabetes mellitus
Management of Obesity
Management of Obesity
Product Highlights
- 100% Genuine product
- Safe and secure payment
- Contactless delivery
- SKU: mounjaro-12.5mg-kwikpen-1122608
₹24,492
5%
OFF
MRP ₹25,781
Inclusive of all taxes
In Stock
100% Genuine
Product Description
Mounjaro 12.5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger. Mounjaro 12.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 12.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.Common side effects of Mounjaro 12.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.Mounjaro 12.5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 12.5mg KwikPen.Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.
Key Benefits
In To improve glycemic control in adults with Type 2 diabetes mellitusMounjaro 12.5mg KwikPen stimulates the body’s natural insulin response when blood sugar is high. It also reduces glucagon secretion, preventing excessive glucose production simultaneously. This dual action helps lower blood sugar levels and improve long-term glucose control.In Management of ObesityMounjaro 12.5mg KwikPen supports weight loss in individuals with obesity when used in conjunction with a healthy diet and regular exercise. It helps reduce appetite and calorie intake, making it easier to eat healthy and maintain a healthier lifestyle. In obese individuals, weight reduction decreases the risk of obesity-related conditions like heart disease, high blood pressure, and type 2 diabetes.show moreshow less
Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common Side Effects :
Nausea
Vomiting
Diarrhea
Abdominal pain
Indigestion
Constipation
Common Side Effects :
Nausea
Vomiting
Diarrhea
Abdominal pain
Indigestion
Constipation
How To Use
Your doctor or nurse will guide you how to use this medicine.
How It Works
Mounjaro 12.5mg KwikPen helps control blood sugar and support weight loss by imitating the effects of two natural hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) in your body. It helps your body release insulin when blood sugar is high and lowers the hormone that raises blood sugar. It also slows down the rate at which food leaves your stomach, so you feel full for longer and eat less. By acting on your brain to reduce hunger, this medicine helps you manage blood sugar better and lose weight more effectively than other medicines that target only one hormone.
Alternate Brands
No alternate brands found for this medicine.
Safety Information & Precautions
Alcohol:
It is not known whether it is safe to consume alcohol with Mounjaro 12.5mg KwikPen. Please consult your doctor.
Pregnancy:
Mounjaro 12.5mg KwikPen may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.Additionally, Mounjaro 12.5mg KwikPen may reduce the effectiveness of oral hormonal contraceptives due to delayed gastric emptying. Patients using oral contraceptives should either switch to a non-oral contraceptive method or use an additional barrier method (e.g., condoms) for 4 weeks after starting Mounjaro 12.5mg KwikPen and for 4 weeks after each dose escalation.
Breastfeeding:
Information regarding the use of Mounjaro 12.5mg KwikPen during breastfeeding is not available. Please consult your doctor.They will weigh its benefits against potential risks to the infant and advise you accordingly.
Driving:
It is not known whether Mounjaro 12.5mg KwikPen alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney:
Mounjaro 12.5mg KwikPen is safe to use in patients with kidney disease. No dose adjustment of Mounjaro 12.5mg KwikPen is recommended.
Liver:
Mounjaro 12.5mg KwikPen is safe to use in patients with liver disease. No dose adjustment of Mounjaro 12.5mg KwikPen is recommended.
It is not known whether it is safe to consume alcohol with Mounjaro 12.5mg KwikPen. Please consult your doctor.
Pregnancy:
Mounjaro 12.5mg KwikPen may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.Additionally, Mounjaro 12.5mg KwikPen may reduce the effectiveness of oral hormonal contraceptives due to delayed gastric emptying. Patients using oral contraceptives should either switch to a non-oral contraceptive method or use an additional barrier method (e.g., condoms) for 4 weeks after starting Mounjaro 12.5mg KwikPen and for 4 weeks after each dose escalation.
Breastfeeding:
Information regarding the use of Mounjaro 12.5mg KwikPen during breastfeeding is not available. Please consult your doctor.They will weigh its benefits against potential risks to the infant and advise you accordingly.
Driving:
It is not known whether Mounjaro 12.5mg KwikPen alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney:
Mounjaro 12.5mg KwikPen is safe to use in patients with kidney disease. No dose adjustment of Mounjaro 12.5mg KwikPen is recommended.
Liver:
Mounjaro 12.5mg KwikPen is safe to use in patients with liver disease. No dose adjustment of Mounjaro 12.5mg KwikPen is recommended.
Quick Tips
Administer Mounjaro 12.5mg KwikPen on the same day each week to maintain consistent blood sugar control. Set a reminder to help you stay on track.
To prevent skin irritation or lumps, administer the medication to different areas of the abdomen, thigh, or upper arm.
Monitor blood sugar levels regularly to prevent hypoglycemia.
Eat small, frequent, balanced meals, and avoid greasy, high-fat foods to reduce nausea.
Drink plenty of water to help counteract potential dehydration caused by nausea, vomiting, or diarrhea.
Be watchful for symptoms such as severe stomach pain, signs of pancreatitis (including severe upper abdominal pain that may radiate to the back, accompanied by nausea, vomiting, or fever), or allergic reactions. Consult a doctor immediately if these symptoms occur.
Mounjaro 12.5mg KwikPen may reduce the effectiveness of oral hormonal contraceptives. Switch to a non-oral contraceptive method or use an additional barrier method (e.g., condoms) for 4 weeks after starting this medicine and for 4 weeks after each dose escalation.
Let doctors know you're taking Mounjaro 12.5mg KwikPen before surgeries, as it may delay stomach emptying and increase aspiration risk.
While Mounjaro 12.5mg KwikPen can aid in weight management, results take time, and maintaining a healthy lifestyle enhances its effectiveness.
To prevent skin irritation or lumps, administer the medication to different areas of the abdomen, thigh, or upper arm.
Monitor blood sugar levels regularly to prevent hypoglycemia.
Eat small, frequent, balanced meals, and avoid greasy, high-fat foods to reduce nausea.
Drink plenty of water to help counteract potential dehydration caused by nausea, vomiting, or diarrhea.
Be watchful for symptoms such as severe stomach pain, signs of pancreatitis (including severe upper abdominal pain that may radiate to the back, accompanied by nausea, vomiting, or fever), or allergic reactions. Consult a doctor immediately if these symptoms occur.
Mounjaro 12.5mg KwikPen may reduce the effectiveness of oral hormonal contraceptives. Switch to a non-oral contraceptive method or use an additional barrier method (e.g., condoms) for 4 weeks after starting this medicine and for 4 weeks after each dose escalation.
Let doctors know you're taking Mounjaro 12.5mg KwikPen before surgeries, as it may delay stomach emptying and increase aspiration risk.
While Mounjaro 12.5mg KwikPen can aid in weight management, results take time, and maintaining a healthy lifestyle enhances its effectiveness.
Missed Dose
If you miss a dose of Mounjaro 12.5mg KwikPen, administer it as soon as possible within four days (96 hours). If more than four days have passed, skip the missed dose and resume your regular schedule. The day of weekly administration can be changed, if necessary, as long as the time between the two doses is at least 3 days (72 hours).